Bladder Cancer News and Research

Latest Bladder Cancer News and Research

Chemotherapy plus immunotherapy improves survival in patients with metastatic urothelial cancer

A clinical trial co-led by Mount Sinai researchers is the first to show that using chemotherapy with immunotherapy resulted in improved survival in patients with an advanced type of bladder cancer.

22 Oct 2023

Can selenium and vitamin E supplementation prevent recurrence and progression of non–muscle-invasive bladder cancer?

The use of vitamin E and selenium in preventing the recurrence and progression of NMIBC.

19 Oct 2023

Bio-inspired drug restores the effectiveness of immune cells in fighting cancer

A new, bio-inspired drug restores the effectiveness of immune cells in fighting cancer, a team led by researchers at The University of Texas at Austin has found.

9 Oct 2023

Breakthrough study shows immunotherapy can help prevent bladder cancer recurrence

The Alliance for Clinical Trials in Oncology today announced that the Alliance Data and Safety Monitoring Board (DSMB) determined that the phase III AMBASSADOR (A031501) trial met one of its dual primary endpoints of disease-free survival (DFS) for the adjuvant treatment of patients with localized muscle-invasive urothelial carcinoma (MIUC) and locally advanced urothelial carcinoma.

5 Oct 2023

Weill Cornell Medicine researcher receives $610,000 grant to study metastasis in bladder cancer

A Weill Cornell Medicine researcher has received a $610,000 grant from the Department of Defense to investigate the mechanisms causing DNA instability that potentially drives metastasis in bladder cancer.

4 Oct 2023

New approach could improve immune checkpoint inhibitor response in MTAP-deficient tumors

Loss of the "housekeeping" gene methylthioadenosine phosphorylase, or MTAP, is a common event in cancer.

28 Sep 2023

AACR Cancer Progress Report provides latest statistics on cancer research and treatment

Today, the American Association for Cancer Research (AACR) released the 13th edition of its annual Cancer Progress Report, which chronicles how basic, translational, and clinical cancer research and cancer-related population sciences - primarily supported by federal investments in the National Institutes of Health (NIH) and the National Cancer Institute (NCI) - remain vitally important to improving health and saving lives.

13 Sep 2023

Unlocking the secret drivers of deadly pancreatic cancer: New target offers hope for treatment

Researchers identify a super-enhancer-regulated RNA-binding protein cascade that drives the growth of pancreatic ductal adenocarcinoma, a deadly form of pancreatic cancer. The discovery offers a promising new avenue for targeted therapy, potentially sidestepping severe side effects associated with other treatments.

10 Sep 2023

New diagnostic tool could revolutionize early bladder cancer detection

Bladder cancer has a five-year survival rate of over 80% when detected early, but this rate declines significantly as the disease progresses to advanced stages.

14 Aug 2023

Single-cell RNA sequencing provides new insights into gastric cancer

A new study led by researchers at The University of Texas MD Anderson Cancer Center provides a deeper understanding of the evolution of the tumor microenvironment during gastric cancer progression.

6 Jul 2023

OICR funding to help six Ontario-based research teams improve the lives of cancer patients

Funding announced today by the Ontario Institute for Cancer Research (OICR) will help six Ontario-based research teams pursue their ultimate goal of improving the lives of people with cancer.

14 Jun 2023

Fred Hutch experts highlight research on cancer treatment advances, survivorship and precision oncology at ASCO

At the 2023 American Society for Clinical Oncology Annual Meeting—to be held June 2-6 in Chicago, Illinois—Fred Hutchinson Cancer Center experts will present research spanning survivorship, advances in treatments and clinical trials, how access to cancer care affects outcomes, integrative medicine and more.

5 Jun 2023

Extended lymphadenectomy for locally advanced bladder cancer provides no patient benefit

An extended lymphadenectomy – removal of additional lymph nodes beyond the extent of the standard procedure – in patients undergoing radical cystectomy (removal of bladder and nearby tissues) because of clinically localized muscle-invasive bladder cancer provides no patient benefit as measured by disease-free survival or overall survival times.

30 May 2023

BCG vaccine associated with reduced risk of Alzheimer's disease and related dementias

The Bacillus Calmette-Guérin (BCG) vaccine - which prevents tuberculosis - offers multiple beneficial effects, and it's currently a recommended therapy for non–muscle-invasive bladder cancer.

19 May 2023

Discovery of new biomarkers could lead to early detection of bladder cancer

A University of Houston biomedical engineer and his team are reporting the discovery of new biomarkers for early detection of bladder cancer (BC), among the most common cancers diagnosed in men in the U.S.

27 Apr 2023

Biomarker signature test can predict tumor response to bladder cancer immunotherapy

In a discovery that could improve the survival of bladder cancer patients, Northwestern Medicine scientists have developed a biomarker signature test to predict which tumors will respond to immunotherapy.

27 Apr 2023

Using a gene signature to predict cancer patient's response to chemotherapy agent cisplatin

Researchers at Cleveland Clinic have taken an important step in predicting which treatment will work for individual cancer patients.

21 Apr 2023

MHRA research evaluates two different approaches to cancer therapies

The report 'Antibody conjugates for targeted delivery of Toll-like receptor 9 agonist to the tumor tissue', published in the PLOS ONE journal, highlights MHRA research which showed that genetic engineering of antibodies used to activate and support the immune system against cancer leads to improvements in their reliability and effectiveness.

13 Apr 2023

New technology allows urologists to identify and remove bladder tumors more easily

UC San Diego Health is the first health system in San Diego County to offer a new technology that detects and monitors bladder cancer in both the clinic and operating room settings by using blue light, white light and an imaging dye that makes cancer cells glow florescent pink.

28 Mar 2023

TTUHSC El Paso scientist receives $2.6 million NIH grant for research on tuberculosis

For over a century, El Paso has long been a sanctuary for individuals suffering from tuberculosis. It will soon be home to groundbreaking research that prevents the debilitating disease.

24 Mar 2023

Bladder Cancer News and Research

Latest Bladder Cancer News and Research

Chemotherapy plus immunotherapy improves survival in patients with metastatic urothelial cancer

Can selenium and vitamin E supplementation prevent recurrence and progression of non–muscle-invasive bladder cancer?

Bio-inspired drug restores the effectiveness of immune cells in fighting cancer

Breakthrough study shows immunotherapy can help prevent bladder cancer recurrence

Weill Cornell Medicine researcher receives $610,000 grant to study metastasis in bladder cancer

New approach could improve immune checkpoint inhibitor response in MTAP-deficient tumors

AACR Cancer Progress Report provides latest statistics on cancer research and treatment

Unlocking the secret drivers of deadly pancreatic cancer: New target offers hope for treatment

New diagnostic tool could revolutionize early bladder cancer detection

Single-cell RNA sequencing provides new insights into gastric cancer

OICR funding to help six Ontario-based research teams improve the lives of cancer patients

Fred Hutch experts highlight research on cancer treatment advances, survivorship and precision oncology at ASCO

Extended lymphadenectomy for locally advanced bladder cancer provides no patient benefit

BCG vaccine associated with reduced risk of Alzheimer's disease and related dementias

Discovery of new biomarkers could lead to early detection of bladder cancer

Biomarker signature test can predict tumor response to bladder cancer immunotherapy

Using a gene signature to predict cancer patient's response to chemotherapy agent cisplatin

MHRA research evaluates two different approaches to cancer therapies

New technology allows urologists to identify and remove bladder tumors more easily

TTUHSC El Paso scientist receives $2.6 million NIH grant for research on tuberculosis

Innovation in neuroscience drug discovery - eBook eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Bladder Cancer News and Research

Latest Bladder Cancer News and Research

Innovation in neuroscience drug discovery - eBook eBook

The evolution of OCT for retinal imaging and disease intervention

Supercharging Next-Gen Antibody Discovery with AI and High-Throughput Experimentation

Prof. Dr. Kristina Kusche-Vihrog

Newsletters you may be interested in